A Cell-free Approach to the Engineering of Corneal Stroma

角膜基质工程的无细胞方法

基本信息

  • 批准号:
    10222698
  • 负责人:
  • 金额:
    $ 41.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-30 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT. Over 25 million people worldwide suffer from corneal blindness in one or both eyes. Corneal transplantation is the only option available to restore vision. However, there is a worldwide donor shortage, and fewer than 1% of patients with corneal blindness receive a transplant each year. Despite the great promise of corneal tissue engineering research to fill this gap, efforts to develop a clinically viable corneal substitute are hindered primarily due to the inability of the existing in vitro culture systems to reproduce the intricate extracellular matrix structure (ECM) of the stroma. Approximately 95% of the stroma is composed of type I collagen-based ECM in which regularly packed collagen fibrils have a uniform diameter and are arranged as orthogonal lamellae, providing the cornea with its unique mechanical and optical properties. The predominantly acellular nature of the stroma has motivated us to pursue a cell-free approach to the engineering of the stroma. We have recently demonstrated that the planar confinement of crowded collagen molecules induces self-organization of the collagen into highly ordered structures. Our objective here is to engineer an acellular stromal analog. Our central hypothesis is that a fully functional corneal stroma can be developed by harnessing the inherent physicochemical properties of collagen molecules. Our efforts to pursue the goals of this proposal will be pursued in three specific aims: In Aim 1, the effects of confining and crowding conditions on the long and short-range organization of collagen fibrils will be determined. Next, the impact of lumican and decorin proteoglycans on collagen ultrastructure (i.e. diameter and spacing) will be elucidated. In Aim 2, we will use a combination of theoretical and numerical modeling to provide an understanding of how crowding and confining conditions, as well as interactions with proteoglycans, impact collagen organization, morphology, and self-assembly. The predictive nature of the model would also enable identifying additional experimental parameters to further optimize the stromal-mimetic collagenous structures. In Aim 3, the long-term in vivo function of the acellular stromal analogs will be delineated by transplanting them into rabbits with deep corneal scars. In addition, in a set of exploratory studies we will investigate whether the native-like physical characteristics of the constructs (e.g., fibrillary organization, diameter and mechanical properties), would improve the differentiation of corneal stromal stem cells into native corneal stromal keratocytes. If successful, the work described here is expected to result in the development of first generation acellular corneal stromal analogs which can restore corneal function upon transplantation. The acellular stroma could be used directly for lamellar transplant in vivo or they could be integrated with the epithelial and endothelial layers to produce a fully functional cornea. Furthermore, the versatile collagen organizing technique that we propose to develop could be used for the production of biomimetic substrates to be integrated into the existing in vitro platforms to mechanistically investigate how various properties of ECM (e.g., organization and diameter) impacts cellular fate and function.
摘要。全世界有超过2500万人患有单眼或双眼角膜失明。角膜

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nima Saeidi其他文献

Nima Saeidi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nima Saeidi', 18)}}的其他基金

The Burmese Python as a Model System for the Study of Metabolism and Organ Regeneration
缅甸蟒蛇作为代谢和器官再生研究的模型系统
  • 批准号:
    10594758
  • 财政年份:
    2022
  • 资助金额:
    $ 41.62万
  • 项目类别:
A Cell-free Approach to the Engineering of Corneal Stroma
角膜基质工程的无细胞方法
  • 批准号:
    10455311
  • 财政年份:
    2021
  • 资助金额:
    $ 41.62万
  • 项目类别:
Central and direct role of the small intestine in the improvement of type 2 diabetes following RYGB
小肠在 RYGB 后改善 2 型糖尿病中的核心和直接作用
  • 批准号:
    10624230
  • 财政年份:
    2020
  • 资助金额:
    $ 41.62万
  • 项目类别:
Central and direct role of the small intestine in the improvement of type 2 diabetes following RYGB
小肠在 RYGB 后改善 2 型糖尿病中的核心和直接作用
  • 批准号:
    10172894
  • 财政年份:
    2020
  • 资助金额:
    $ 41.62万
  • 项目类别:
Central and direct role of the small intestine in the improvement of type 2 diabetes following RYGB
小肠在 RYGB 后改善 2 型糖尿病中的核心和直接作用
  • 批准号:
    10398156
  • 财政年份:
    2020
  • 资助金额:
    $ 41.62万
  • 项目类别:
The Burmese Python as a Model System for the Study of Metabolism and Organ Regeneration
缅甸蟒蛇作为代谢和器官再生研究的模型系统
  • 批准号:
    10042881
  • 财政年份:
    2020
  • 资助金额:
    $ 41.62万
  • 项目类别:
A Cell-free Approach to the Engineering of Corneal Stroma
角膜基质工程的无细胞方法
  • 批准号:
    9364715
  • 财政年份:
    2017
  • 资助金额:
    $ 41.62万
  • 项目类别:
A Cell-free Approach to the Engineering of Corneal Stroma
角膜基质工程的无细胞方法
  • 批准号:
    9750089
  • 财政年份:
    2017
  • 资助金额:
    $ 41.62万
  • 项目类别:
A Cell-free Approach to the Engineering of Corneal Stroma
角膜基质工程的无细胞方法
  • 批准号:
    10226603
  • 财政年份:
    2017
  • 资助金额:
    $ 41.62万
  • 项目类别:
Gastrointestinal Weight Loss Surgery Regulates Glucose Metabolism via Intestinal Metabolic Remodeling
胃肠减肥手术通过肠道代谢重塑调节葡萄糖代谢
  • 批准号:
    9285792
  • 财政年份:
    2015
  • 资助金额:
    $ 41.62万
  • 项目类别:

相似海外基金

Establishment of novel osteochondral allografting combined with growth factor- collagen-binding domain fusion technology
新型同种异体骨软骨移植联合生长因子-胶原蛋白结合域融合技术的建立
  • 批准号:
    26462277
  • 财政年份:
    2014
  • 资助金额:
    $ 41.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Translating PTH Therapy as an Adjuvant for Structural Allografting
将 PTH 疗法转化为结构性同种异体移植的佐剂
  • 批准号:
    8344380
  • 财政年份:
    2012
  • 资助金额:
    $ 41.62万
  • 项目类别:
Allografting for Lukemia
白血病同种异体移植
  • 批准号:
    8260361
  • 财政年份:
    2011
  • 资助金额:
    $ 41.62万
  • 项目类别:
Composite Allografting for Promoting Survival of Corneal Transplants
复合同种异体移植促进角膜移植的存活
  • 批准号:
    7878675
  • 财政年份:
    2009
  • 资助金额:
    $ 41.62万
  • 项目类别:
Composite Allografting for Promoting Survival of Corneal Transplants
复合同种异体移植促进角膜移植的存活
  • 批准号:
    7677758
  • 财政年份:
    2009
  • 资助金额:
    $ 41.62万
  • 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
  • 批准号:
    7466112
  • 财政年份:
    2008
  • 资助金额:
    $ 41.62万
  • 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
  • 批准号:
    8010394
  • 财政年份:
    2008
  • 资助金额:
    $ 41.62万
  • 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
  • 批准号:
    8208131
  • 财政年份:
    2008
  • 资助金额:
    $ 41.62万
  • 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
  • 批准号:
    7575273
  • 财政年份:
    2008
  • 资助金额:
    $ 41.62万
  • 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
  • 批准号:
    7765518
  • 财政年份:
    2008
  • 资助金额:
    $ 41.62万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了